Primary lateral sclerosis

Primary lateral sclerosis

Primary lateral sclerosis (PLS) is a rare motor neuron disease where symptoms progress slowly over a number of years. PLS is related to ALS, but has a much better prognosis as only the upper (central) motor neurons are involved.  

Life span could essentially be normal, although it may be life-limiting, depending on whether it remains as pure PLS or develops into ALS. Within the first four years from developing symptoms, people thought to have PLS can additionally develop lower motor neuron symptoms leading to the diagnosis ALS.

PLS affects the nerve cells that send messages from the brain down the spinal cord and on to the muscles. This causes weakness, especially in the legs, and stiffness in the muscles and joints (known as spasticity). Some people develop weakness and stiffness in the muscles used for speech and swallowing too. Not all symptoms necessarily happen to everyone and they do not usually develop at the same time.

PLS typically affects people aged 35-65 years. There is no cure or treatment for PLS, but symptoms can be managed to improve quality of life.

PLS occurs sporadically in the majority of affected individuals. Sporadic is the term used for cases of the disease where there is no family history. The causes of PLS and related motor neuron diseases ALS and PMA are not known, and research is ongoing. It is thought that a combination of environmental and genetic factors play a part, but it is not currently possible to give a clear answer about the precise triggers. Research of the causes of PLS, ALS and PMA is ongoing.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not